Plain-English translation of NCT07039279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to treating 'diabesity' — the combination of type 2 diabetes and obesity — in younger Chinese adults. Rather than relying on medication alone, the study uses a team of doctors, dietitians, and counselors who work together with you, using digital tools and behavioral support to help you lose weight and better control your blood sugar. The goal is to see whether this comprehensive approach works better than the usual care most patients receive.
Many people with type 2 diabetes struggle to reach healthy blood sugar and weight targets because they don't get enough support, take medications that can cause weight gain, or don't have help with the behavioral changes needed. This trial exists to test whether having a whole team backing you up — plus counseling and digital support — can break that cycle and give you better long-term health outcomes.
You likely qualify if…
You likely don't qualify if…
If you join the treatment group, you'll work with a team that includes an endocrinologist (diabetes specialist), dietitian, and psychologist over 3 years. You'll attend regular visits, use a digital platform and AI chatbot to track your progress, participate in counseling to help change eating and lifestyle habits, get peer support from others in the program, and receive biofeedback on your progress. The control group receives standard diabetes care. Throughout the study, your blood sugar, weight, and overall health will be monitored.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Hong Kong